Joinn Laboratories (06127) plans to invest no more than 10 million yuan to participate in the establishment of a biopharmaceutical fund.

Joinn Laboratories (06127) announced that in order to fully leverage the advantages of professional investment institutions in resources, professional judgment, and investment management, the company or its designated subsidiary intends to sign a "Partnership Agreement" with Shenzhen Yifeng Investment Management Enterprise (Limited Partnership) (hereinafter referred to as "Yifeng Capital"), Shenzhen Yifeng Mingyuan Technology Co., Ltd. (hereinafter referred to as "Yifeng Mingyuan") and other related parties to initiate the establishment of Shenzhen Yifeng Guangming Science City Seed Fund (Limited Partnership) (hereinafter referred to as "this fund" or "partnership enterprise"). The partnership enterprise will focus on developing strategic emerging industries supported and encouraged by the Shenzhen government, future industries, and other industries that are key to the development of the municipal government, with a focus on investments in the field of biomedicine and high-end medical devices. The company or its designated subsidiary will subscribe capital contributions of no more than 10 million RMB as a limited partner. The company held the fifteenth meeting of the fourth session of the Board of Directors on August 26, 2025, and approved the "Proposal on the Company's Participation with Professional Investment Institutions in Investing to Establish a Fund", agreeing to invest up to 10 million RMB to participate in the establishment of this fund. The announcement stated that this investment in the fund aligns with the company's long-term development strategy. By leveraging the resources, professional experience, and investment management expertise of the cooperating parties, it will help the company broaden its industrial investment channels and provide momentum and security for the sustainable high-quality development of the company. Furthermore, with the management experience and risk control system of the fund manager, it will help control investment risks, ensure the quality of investment projects, and protect the interests of the company and shareholders. This investment will not have a significant adverse impact on the company's production and operation, nor will it involve management changes, personnel arrangements, land leases, or create situations of industry competition.